Considerations in the management of the patient with comorbid depression and anxiety
- PMID: 12613410
- DOI: 10.1111/j.1745-7599.2003.tb00251.x
Considerations in the management of the patient with comorbid depression and anxiety
Abstract
Purpose: To provide clinicians with guidelines for the assessment, evaluation, diagnosis, and management of comorbid depression and anxiety in the primary care setting.
Data sources: Research-based articles in the medical and psychiatric literature, literature reviews by experts in the field, and DSM-IV-TR.
Conclusions: Comorbid anxiety and depression occurs at a high rate in primary care, and is costly to both the individual and to society. These patients most often present in primary care settings, have more severe symptoms, and require more health care resources. The presentation of depression and anxiety together pose complicated diagnostic and treatment challenges, leading to inadequate diagnosis and treatment resulting in unnecessary patient distress and increased utilization of health care services.
Implications for practice: This article is a review of comorbid depression and anxiety with a focus upon societal and patient significance and impact, under recognition and under treatment, diagnostic challenges, medical comorbidity, treatment considerations, and educational strategies. Effective assessment, evaluation, diagnosis and treatment can lead to better treatment outcomes and improved quality of life in primary care patients.
Similar articles
-
Prevalence, recognition, and treatment of comorbid depression and anxiety.J Clin Psychiatry. 2001;62 Suppl 24:6-10. J Clin Psychiatry. 2001. PMID: 11676431 Review.
-
Anxiety associated with comorbid depression.J Clin Psychiatry. 2002;63 Suppl 14:22-6. J Clin Psychiatry. 2002. PMID: 12562115 Review.
-
Quality of mental health care for youth with asthma and comorbid anxiety and depression.Med Care. 2006 Dec;44(12):1064-72. doi: 10.1097/01.mlr.0000237421.17555.8f. Med Care. 2006. PMID: 17122709
-
Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.Am J Psychiatry. 1996 Oct;153(10):1293-300. doi: 10.1176/ajp.153.10.1293. Am J Psychiatry. 1996. PMID: 8831437 Clinical Trial.
-
Management of comorbid anxiety and depression.J Clin Psychiatry. 1995;56 Suppl 2:10-3. J Clin Psychiatry. 1995. PMID: 7844101 Review.
Cited by
-
Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers.World J Gastroenterol. 2005 Apr 21;11(15):2313-8. doi: 10.3748/wjg.v11.i15.2313. World J Gastroenterol. 2005. PMID: 15818744 Free PMC article.
-
Comorbidity of anxiety and depression in children and adolescents: 20 years after.Psychol Bull. 2014 May;140(3):816-45. doi: 10.1037/a0034733. Epub 2013 Nov 11. Psychol Bull. 2014. PMID: 24219155 Free PMC article. Review.
-
Variability of the Prevalence of Depression in Function of Sociodemographic and Environmental Factors: Ecological Model.Front Psychol. 2018 Nov 12;9:2182. doi: 10.3389/fpsyg.2018.02182. eCollection 2018. Front Psychol. 2018. PMID: 30483190 Free PMC article.
-
Group Mindfulness-Integrated Cognitive Behavior Therapy (MiCBT) Reduces Depression and Anxiety and Improves Flourishing in a Transdiagnostic Primary Care Sample Compared to Treatment-as-Usual: A Randomized Controlled Trial.Front Psychiatry. 2022 May 31;13:815170. doi: 10.3389/fpsyt.2022.815170. eCollection 2022. Front Psychiatry. 2022. PMID: 35711582 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical